Two New FDA-Approved Treatments for RKD

TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to aprende más. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.

RECURSOS

/

ENCUENTRA UN ESPECIALISTA

/

CONTACTO

Raquel Slattery

Director, Events Strategy

Rachel Slattery serves as the Director of Event Strategy for NephCure. Before joining the team in May 2019, she started her career in the event planning industry at the Chamber of Commerce for Greater Philadelphia and has experience coordinating small to large scale events of all types from start to finish. Rachel is passionate about turning events into unforgettable experiences and helping others along the way. In her spare time, she loves to travel, hike and spend time with her Maltipoo dog, Peanut!

Rey de Prusia, Pensilvania

Noticias relacionadas

NOTICIAS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NOTICIAS

NephCure Specialist of the Month: Dr. Rupali Avasare

NOTICIAS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

NOTICIAS

NephCure Specialist of the Month: Dr. Fahad Aziz

Regístrese para recibir las últimas actualizaciones de NephCure.

INSCRIBIRSE
Este campo es para fines de validación y no debe modificarse.